共 50 条
- [1] Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2017, 18 (03): : 273 - 292
- [2] Comment on “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany” [J]. The European Journal of Health Economics, 2018, 19 : 471 - 472
- [3] Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany" [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (03): : 471 - 472
- [4] Authors’ reply to Gandjour: “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany” [J]. The European Journal of Health Economics, 2018, 19 : 473 - 481
- [5] Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany" [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (03): : 473 - 481
- [7] Cost-effectiveness of pneumococcal conjugate vaccination in Georgia [J]. VACCINE, 2015, 33 : A219 - A226
- [8] The cost-effectiveness of pneumococcal conjugate vaccination in Australia [J]. VACCINE, 2004, 22 (9-10) : 1138 - 1149
- [9] Cost-effectiveness of pneumococcal conjugate vaccination in Croatia [J]. VACCINE, 2015, 33 : A209 - A218
- [10] COST-EFFECTIVENESS OF CONJUGATE PNEUMOCOCCAL VACCINATION IN CROATIA [J]. VALUE IN HEALTH, 2015, 18 (07) : A586 - A586